|
|
Volumn 130, Issue 6, 1999, Pages 531-532
|
|
Newer asthma therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BECLOMETASONE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
NEUROKININ 2 RECEPTOR ANTAGONIST;
PHOSPHODIESTERASE INHIBITOR;
PREDNISONE;
SALBUTAMOL;
THEOPHYLLINE;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
THROMBOXANE RECEPTOR BLOCKING AGENT;
ZAFIRLUKAST;
ZILEUTON;
ASTHMA;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
FORCED EXPIRATORY VOLUME;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
|
|
EID: 0033574196
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-130-6-199903160-00018 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (10)
|
